Medicare Enrolled

Dr. Emma-Ruth Paz-Querubin, APN

Physician Assistant · Voorhees, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
705 WHITE HORSE RD, Voorhees, NJ 08043
8564351777
In practice since 2009 (16 years)
NPI: 1790015659 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Paz-Querubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Paz-Querubin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Paz-Querubin

Dr. Emma-Ruth Paz-Querubin is a physician assistant in Voorhees, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Paz-Querubin performed 18 Medicare services across 16 unique beneficiaries.

Between the years covered by Open Payments, Dr. Paz-Querubin received a total of $5,149 from 51 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Paz-Querubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 18 Medicare services $5,149 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18
Medicare services
Bottom 6% in NJ for physician assistant
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
16
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $67 $296
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,149
Total received (2022-2024)
Avg $1,716/year across 3 years
Top 6% in NJ for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,623 (89.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$527 (10.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,504
2023
$1,375
2022
$1,269

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$267
Novartis Pharmaceuticals Corporation
$223
E.R. Squibb & Sons, L.L.C.
$210
Daiichi Sankyo Inc.
$198
Incyte Corporation
$197
Merck Sharp & Dohme LLC
$154
SOBI, INC
$104
Genmab U.S., Inc.
$92
Eisai Inc.
$87
PFIZER INC.
$71
Celgene Corporation
$69
Genentech USA, Inc.
$68
Bayer Healthcare Pharmaceuticals Inc.
$61
Stemline Therapeutics Inc.
$54
Mirati Therapeutics, Inc.
$52
Gilead Sciences, Inc.
$51
Janssen Biotech, Inc.
$51
RECORDATI_RARE_DISEASES_INC.
$49
Lilly USA, LLC
$48
Aveo Pharmaceuticals, Inc.
$45
Novocure Inc.
$41
SERVIER PHARMACEUTICALS LLC
$40
Apellis Pharmaceuticals, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$38
ABBVIE INC.
$32
Pharmacosmos Therapeutics Inc.
$29
TerSera Therapeutics LLC
$19
Acrotech Biopharma Inc.
$19
ARRAY BIOPHARMA INC
$19
GlaxoSmithKline, LLC.
$17
Astellas Pharma US Inc
$16
Kyowa Kirin, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Cumberland Pharmaceuticals, Inc.
$15
Top 3 companies account for 28.0% of 2024 payments
All-time payments by company (2022-2024) ›
EMD Serono, Inc.
$412
Incyte Corporation
$398
E.R. Squibb & Sons, L.L.C.
$382
AstraZeneca Pharmaceuticals LP
$284
Novartis Pharmaceuticals Corporation
$267
Daiichi Sankyo Inc.
$262
Merck Sharp & Dohme LLC
$212
Celgene Corporation
$202
Pharmacosmos Therapeutics Inc.
$161
GlaxoSmithKline, LLC.
$156
Takeda Pharmaceuticals U.S.A., Inc.
$153
Pharmacyclics LLC, An AbbVie Company
$149
Lilly USA, LLC
$143
Pharmacyclics LLC, an AbbVie Company
$134
Bayer Healthcare Pharmaceuticals Inc.
$134
PFIZER INC.
$120
Rigel Pharmaceuticals, Inc.
$112
SOBI, INC
$104
Genmab U.S., Inc.
$92
Eisai Inc.
$87
Genentech USA, Inc.
$82
AVEO Pharmaceuticals, Inc.
$78
Stemline Therapeutics Inc.
$73
Gilead Sciences, Inc.
$69
Janssen Biotech, Inc.
$64
GENZYME CORPORATION
$63
Exelixis Inc.
$54
Mirati Therapeutics, Inc.
$52
RECORDATI_RARE_DISEASES_INC.
$49
ABBVIE INC.
$49
Astellas Pharma US Inc
$46
Seagen Inc.
$46
Aveo Pharmaceuticals, Inc.
$45
Novocure Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$40
SERVIER PHARMACEUTICALS LLC
$40
Apellis Pharmaceuticals, Inc.
$39
ARRAY BIOPHARMA INC
$36
G1 Therapeutics, Inc.
$22
Heron Therapeutics, Inc.
$21
TerSera Therapeutics LLC
$19
Acrotech Biopharma Inc.
$19
Ipsen Biopharmaceuticals, Inc
$17
Taiho Oncology, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Kyowa Kirin, Inc.
$15
MorphoSys, US Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Mylan Institutional Inc.
$15
Puma Biotechnology, Inc.
$15
Cumberland Pharmaceuticals, Inc.
$15
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · BELEODAQ · BRAFTOVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · Columvi · DOPTELET · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LONSURF · LORBRENA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Optune · Orserdu · PADCEV · Padcev · Pomalyst · Poteligeo · REBLOZYL · RETEVMO · SANCUSO · SYLVANT · SYNAGIS · Stivarga · TECVAYLI · Tavalisse · Tazverik · Tibsovo · Tivdak · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Venclexta · Voranigo · Xermelo · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for physician assistant in NJ.

Looking for a physician assistant in Voorhees?
Compare physician assistants in the Voorhees area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
1,082
Per 100K population
206.5
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Paz-Querubin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 6% of NJ peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Paz-Querubin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Paz-Querubin performed 18 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Paz-Querubin receive payments from pharmaceutical companies?
Yes. Dr. Paz-Querubin received a total of $5,149 from 51 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Paz-Querubin's costs compare to other physician assistants in Voorhees?
Dr. Paz-Querubin's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Paz-Querubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →